Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Victor Weigman, Ph.D. | June 02, 2016

The Benefits of Incorporating Genomic Testing into Immuno-Oncology Clinical Trials

Q2 Solutions offers a range of genomic services to support drug discovery, precision medicine and clinical development. There are several advantages to incorporating genomic testing into immuno-oncology clinical trials. Watch this video to see Victor Weigman, Q2 Solutions Translational Genomics, discuss how incorporating genomic testing facilitates research and clinical trial design to realize genomics-based medicine. You’ll also learn how genomic testing expands insight into more treatment options based on a patient’s tumor classification.

Related Services:
Personalizing oncology with genomics

Next-generation sequencing will transform oncology clinical trials and treatments for cancer

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Read More